• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October

    10/16/23 10:07:59 AM ET
    $ALDX
    $APH
    $BIOC
    $LQR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electrical Products
    Technology
    Get the next $ALDX alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday.

    The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also rose, gaining, 0.60% to 4,353.60.

    Check This Out: Top 3 Health Care Stocks That May Implode This Quarter

     

    Leading and Lagging Sectors

     

    Energy shares climbed by 1.1% on Friday.

    In trading on Friday, information technology shares rose by just 0.2%.

     

    Top Headline

     

    The NY Empire State Manufacturing Index declined to -4.6 in October from 1.9 in the prior month, compared to market estimates for a reading of -7.

     

    Equities Trading UP

     

    LQR House Inc. (NASDAQ:LQR) shares shot up 76% to $0.3030. LQR House announced that through its custom marketing campaign and strategic efforts, Von Payne Whiskey is now displayed on the shelves of the retail giant, Costco.

    Shares of PCTEL, Inc. (NASDAQ:PCTI) got a boost, shooting 47% to $6.86. On Friday, Amphenol Corp (NYSE:APH) inked a deal to acquire PCTEL for around $139.7 million.

    Momentus Inc. (NASDAQ:MNTS) shares were also up, gaining 32% to $4.11.

     

    Equities Trading DOWN

     

    Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares dropped 60% to $2.17. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.

    Shares of Biocept, Inc. (NASDAQ:BIOC) were down 58% to $0.4239. Biocept said Antonino Morales tendered his resignation as the company's President And Chief Executive Officer, effective on Oct. 13, 2023. The company also Filed voluntary petition under the provisions of Chapter 7 in Bankruptcy Court.

    Omeros Corporation (NASDAQ:OMER) was down, falling 47% to $1.20 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.

    Also Check This Out: JPMorgan To Rally Over 29%? Here Are Top 10 Analyst Forecasts For Monday

     

    Commodities

     

    In commodity news, oil traded down 0.3% to $87.47 while gold traded down 0.5% at $1,932.40.

    Silver traded down 0.2% to $22.85 on Friday while copper rose 0.2% to $3.5765.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 rose 0.1% London’s FTSE 100 rose 0.3% while Spain’s IBEX 35 Index rose 0.4% The German DAX rose 0.1% French CAC 40 rose 0.2%, while Italy’s FTSE MIB Index gained 0.5%.

    The Eurozone recorded a trade surplus of EUR 6.7 billion in August versus a year-ago gap of EUR 54.4 billion. The annual inflation rate in Italy eased to 5.3% in September from 5.4% a month ago. German wholesale prices fell for the sixth straight period by 4.1% year-over-year in September.

     

    Asia Pacific Markets

     

    Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 2.03%, China’s Shanghai Composite Index falling 0.46% and Hong Kong’s Hang Seng Index dropping 0.97%. India’s S&P BSE Sensex, meanwhile, slipped 0.2%.

    India's wholesale prices fell by 0.26% year-over-year in September following a 0.52% decline in the previous month. Industrial production in Japan fell by 0.7% month-over-month in August.

     

    Economics

     

    The NY Empire State Manufacturing Index declined to -4.6 in October from 1.9 in the prior month, compared to market estimates for a reading of -7.

    Now Read This: Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying

    Get the next $ALDX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALDX
    $APH
    $BIOC
    $LQR

    CompanyDatePrice TargetRatingAnalyst
    Amphenol Corporation
    $APH
    3/31/2026$145.00Buy
    Jefferies
    Aldeyra Therapeutics Inc.
    $ALDX
    3/18/2026$2.00Buy → Neutral
    H.C. Wainwright
    Amphenol Corporation
    $APH
    1/12/2026$156.00Equal Weight → Overweight
    Barclays
    Amphenol Corporation
    $APH
    10/15/2025$150.00Neutral → Buy
    BofA Securities
    Amphenol Corporation
    $APH
    10/8/2025$120.00Equal Weight
    Barclays
    Omeros Corporation
    $OMER
    6/10/2025$9.00Buy
    H.C. Wainwright
    Amphenol Corporation
    $APH
    4/24/2025$85.00Equal Weight → Overweight
    Fox Advisors
    Omeros Corporation
    $OMER
    12/23/2024$36.00Buy
    D. Boral Capital
    More analyst ratings

    $ALDX
    $APH
    $BIOC
    $LQR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Livingston Robert bought $1,285,080 worth of shares (10,000 units at $128.51), increasing direct ownership by 8% to 135,720 units (SEC Form 4)

    4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)

    2/6/26 4:01:08 PM ET
    $APH
    Electrical Products
    Technology

    Principal Financial Officer Alfieri Michael bought $13,250 worth of shares (2,500 units at $5.30) (SEC Form 4)

    4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)

    8/15/25 4:09:59 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hoffman Alexandra bought $8,125 worth of shares (8,000 units at $1.02), increasing direct ownership by 959% to 8,834 units (SEC Form 4)

    4 - LQR House Inc. (0001843165) (Issuer)

    12/2/24 9:00:52 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    $ALDX
    $APH
    $BIOC
    $LQR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Brady Todd C

    4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)

    3/31/26 4:17:57 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Douglas Richard

    4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)

    3/20/26 4:17:41 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Alfieri Michael

    4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)

    3/19/26 5:29:03 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALDX
    $APH
    $BIOC
    $LQR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Omeros Corporation

    SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject)

    4/23/26 10:08:39 AM ET
    $OMER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Momentus Inc.

    SCHEDULE 13G - Momentus Inc. (0001781162) (Subject)

    4/22/26 5:10:45 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form S-3 filed by Momentus Inc.

    S-3 - Momentus Inc. (0001781162) (Filer)

    4/21/26 5:15:28 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    $ALDX
    $APH
    $BIOC
    $LQR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amphenol Releases 2025 Sustainability Report

    Amphenol Corporation (NYSE:APH) today released its 2025 Sustainability Report. "I am pleased to share Amphenol's 2025 Sustainability Report, which highlights our many areas of progress and success throughout the Company," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "2025 was an exceptional year for Amphenol. Our global team delivered record-breaking financial performance, with outstanding sales growth and industry-leading profitability, all while strengthening and remaining true to our entrepreneurial culture. We are also proud to have made meaningful progress on our sustainability program. During 2025, we completed three of our goals aligned with the United Na

    4/22/26 8:00:00 AM ET
    $APH
    Electrical Products
    Technology

    Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

    SAN MATEO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026. "We are delighted to welcome Dr. Andreas Grauer to our executive leadership team as Chief Medical Officer. Dr. Grauer has an extensive track record in leading clinical development

    4/20/26 7:00:00 AM ET
    $OMER
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)

    – Permanent, product-specific J-code facilitates efficient claims and reimbursement – Omeros Corporation (NASDAQ:OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent Healthcare Common Procedure Coding System (HCPCS) J-code for YARTEMLEA®. The J-code for YARTEMLEA (J1289) simplifies and streamlines billing and reimbursement for patients covered by U.S. government programs (e.g., Medicare) and commercial payers. The J-code will become effective July 1, 2026. "For patients with TA-TMA, access to effective treatment without unnecessary delay is critical," said Gregory A. Demopulos, M.D., Chairman and Chief Executive Officer of Omeros. "

    4/16/26 8:45:00 AM ET
    $OMER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALDX
    $APH
    $BIOC
    $LQR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Amphenol with a new price target

    Jefferies resumed coverage of Amphenol with a rating of Buy and set a new price target of $145.00

    3/31/26 8:09:23 AM ET
    $APH
    Electrical Products
    Technology

    Aldeyra Therapeutics downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Aldeyra Therapeutics from Buy to Neutral and set a new price target of $2.00

    3/18/26 8:20:05 AM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amphenol upgraded by Barclays with a new price target

    Barclays upgraded Amphenol from Equal Weight to Overweight and set a new price target of $156.00

    1/12/26 7:37:33 AM ET
    $APH
    Electrical Products
    Technology

    $ALDX
    $APH
    $BIOC
    $LQR
    Leadership Updates

    Live Leadership Updates

    View All

    Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

    SAN MATEO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026. "We are delighted to welcome Dr. Andreas Grauer to our executive leadership team as Chief Medical Officer. Dr. Grauer has an extensive track record in leading clinical development

    4/20/26 7:00:00 AM ET
    $OMER
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amphenol Announces Board Succession Plan

    Amphenol Corporation (NYSE:APH) today announced that the Board of Directors has appointed R. Adam Norwitt, currently serving as President and Chief Executive Officer, to the additional role of Chairman of the Board, effective on the date of the Company's 2026 Annual Meeting of Stockholders, which is expected to be in May 2026. After more than five decades with Amphenol, including serving as President from 1987 to 2006, Chief Executive Officer from 1996 to 2008 and as Chairman of the Board since 1997, Martin H. Loeffler intends to retire from the Board also effective in May. As part of this leadership transition, David P. Falck, who has served as a Director since 2013 and Presiding Director

    2/4/26 4:44:00 PM ET
    $APH
    Electrical Products
    Technology

    Amphenol Appoints Sanjiv Lamba to Board of Directors

    Amphenol Corporation (NYSE:APH) today announced that Sanjiv Lamba has been appointed to Amphenol's board of directors. With his appointment, the size of the Company's board has increased to nine members. Mr. Lamba is currently the Chief Executive Officer of Linde plc (NASDAQ:LIN), a leading global industrial gases and engineering company. Mr. Lamba is based in Danbury, Connecticut and was promoted to the role of Chief Executive Officer of Linde in 2022 and has been named Chairman of Linde's board effective January 31, 2026. He brings nearly thirty years of global leadership experience to Amphenol's board. Prior to his current role as CEO, Mr. Lamba served as Chief Operating Officer of Lin

    1/8/26 5:08:00 PM ET
    $APH
    $LIN
    Electrical Products
    Technology
    Major Chemicals
    Basic Materials

    $ALDX
    $APH
    $BIOC
    $LQR
    Financials

    Live finance-specific insights

    View All

    Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results

    – Conference Call Today at 4:30 p.m. ET Omeros Corporation (NASDAQ:OMER) today announced recent highlights and developments as well as financial results for the fourth quarter and year ended December 31, 2025, which include: Net income for the fourth quarter of 2025 was $86.5 million, or $1.22 per share, compared to a net loss of $31.4 million, or $0.54 per share, for the fourth quarter of 2024. For the year ended December 31, 2025, net loss was $3.4 million, or $0.05 per share, compared to a net loss of $156.8 million, or $2.70 per share, in the prior year. Fourth quarter results include a net gain of $237.6 million tied to the zaltenibart transaction with Novo Nordisk. The fourth

    3/31/26 4:02:00 PM ET
    $OMER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026

    Omeros Corporation (NASDAQ:OMER) today announced that it will issue its financial results for the fourth quarter and year ended December 31, 2025, on Tuesday, March 31, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company's financial results. Conference Call Details and Webcast Link Instructions To access the live webcast, please click here or visit the "Upcoming Events" section of the Investor Relations page of Omeros' website. A replay of the call will be available for 90 days in the "Archived Events" section of the Inves

    3/26/26 8:45:00 AM ET
    $OMER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amphenol Announces First Quarter 2026 Dividend

    Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the first quarter 2026 dividend on its Common Stock in the amount of $0.25 per share at its meeting held on February 4, 2026. The Company will pay this first quarter 2026 dividend on April 14, 2026 to shareholders of record as of March 23, 2026. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial, high-speed, fiber optic and specialty cable. Amphenol designs, manufactures and assembles its products at facilities in appro

    2/5/26 8:00:00 AM ET
    $APH
    Electrical Products
    Technology

    $ALDX
    $APH
    $BIOC
    $LQR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by LQR House Inc.

    SC 13D/A - LQR House Inc. (0001843165) (Subject)

    11/25/24 4:41:10 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Momentus Inc.

    SC 13G/A - Momentus Inc. (0001781162) (Subject)

    11/14/24 5:14:58 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Momentus Inc.

    SC 13G/A - Momentus Inc. (0001781162) (Subject)

    11/14/24 5:14:34 PM ET
    $MNTS
    Military/Government/Technical
    Industrials